Episode
How Merck Uses AI to Improve Clinical Research
- Podcast
- C-Suite Perspectives
- Published
- May 26, 2026
- Duration seconds
- 1606
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/c-suite-perspectives-3733069/episodes/how-merck-uses-ai-to-improve-clinical-research/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/c-suite-perspectives-3733069/how-merck-uses-ai-to-improve-clinical-research.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Generative AI and other technologies are transforming clinical research and trials. Find out how it's done. The clinical trials sector is risk-averse, heavily regulated, and not often thought of as a technology first-mover. How is Merck changing that perception by using AI to improv e insights, innovation, and operations? Join Steve Odland and guest Jennifer Sheller, senior vice president and head of global clinical trial operations at Merck , to find out how the company is using AI for clinical research and clinical trial s , why "human in the loop" remains essential , and how Merck thinks about the ethical , safety, and privacy considerations of digital health. For more from The Conference Board: How AI Can Help Remedy the US Health Care Workforce Crisis Health Care Workforce Policy Summit: Insight Summary Navigating the Health Care Landscape in 2026